InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,893.62
(
0.39%
)
US TECH 100
19,996.80
(
0.67%
)
Dow Jones
43,389.60
(
-0.13%
)
Brent Oil
72.99
(
0.08%
)
Bitcoin
91,885.89
(
1.48%
)
Post# of 253656
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120739
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: masterlongevity post# 126064

Friday, 09/02/2011 8:07:29 AM

Friday, September 02, 2011 8:07:29 AM

Post# of 253656
As far as I can tell, it will not be approved ever. The product Teva is trying to pass off to the FDA as a generic copy of Lovenox was developed and is manufactured by the Italian company, ItalFarmaco. It’s essentially the same drug that ItalFarmaco licensed to India’s Lupin for sale in India under the brand name, Lupenox. Teva’s role in the project is limited to the FDA submissions and the prospective US distribution. All this comes from a well-placed source in the industry.

Related info can be found in #msg-59485489, #msg-55669281, and #msg-55670004.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up